Wnt/beta-catenin signaling pathway as a novel cancer drug target. - Wikidata - awgldk - TriplyDB

Wnt/beta-catenin signaling pathway as a novel cancer drug target.

Wnt/beta-catenin signaling pathway as a novel cancer drug target.

http://www.wikidata.org/entity/Q35971885

about

A systematic screen for micro-RNAs regulating the canonical Wnt pathway SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications Lung cancer-initiating cells: a novel target for cancer therapy Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability TRAIL-Based High Throughput Screening Reveals a Link between TRAIL-Mediated Apoptosis and Glutathione Reductase, a Key Component of Oxidative Stress Response Prediction of potential drug targets based on simple sequence properties.WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer.Downregulation of microRNA-30d promotes cell proliferation and invasion by targeting LRH-1 in colorectal carcinoma.Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44+ Gastric Cancer Stem Cells.Atrial natriuretic peptide: a magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulators From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways.Inhibition of Tcf-4 induces apoptosis and enhances chemosensitivity of colon cancer cells Defective osteogenic differentiation in the development of osteosarcoma.Esculetin suppresses proliferation of human colon cancer cells by directly targeting β-catenin.Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway Euodia sutchuenensis Dode extract stimulates osteoblast differentiation via Wnt/β-catenin pathway activation Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen.Inhibitory effect of 2-(piperidinoethoxyphenyl)-3-(4-hydroxyphenyl)-2H-benzo(b)pyran (K-1) on human primary endometrial hyperplasial cells mediated via combined suppression of Wnt/β-catenin signaling and PI3K/Akt survival pathway.A Resource of Quantitative Functional Annotation for Homo sapiens Genes Altering cancer transcriptomes using epigenomic inhibitors Oncogenesis and cancer stem cells: current opinions and future directions.Enhancement of Radiation Sensitivity in Lung Cancer Cells by a Novel Small Molecule Inhibitor That Targets the β-Catenin/Tcf4 Interaction Modulation of Wnt/β-catenin signaling pathway by bioactive food components.Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.Inhibitory effects of lupeal acetate of Cortex periplocae on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis Increased nuclear β-catenin expression in oral potentially malignant lesions: A marker of epithelial dysplasia Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells.Lithium Attenuates TGF-β(1)-Induced Fibroblasts to Myofibroblasts Transition in Bronchial Fibroblasts Derived from Asthmatic Patients.Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.The Antitumor Activity of Antrodia camphorata in Melanoma Cells: Modulation of Wnt/β-Catenin Signaling Pathways.Gene expression profiling in the discovery, optimization and development of novel drugs: one universal screening platform.The Current and Future Therapies for Human Osteosarcoma.

P2860

Q21134995-75C2165B-6830-4FA9-ADF6-D4495C4806B6 Q24685799-3A614C0C-321F-48AC-A4F5-D844DFC3E446 Q26764899-99511EC4-0B5D-424B-9C01-F04BADE9184F Q26824222-1BDE797F-EC73-4E34-AA0A-C8F8280404C8 Q26851275-886EF6C1-E8FA-4682-AC79-4B95F7CC0289 Q26865911-2C178538-523E-4B79-8135-54C5743CE8AE Q28078208-A2D33C0D-8CF1-4D6E-8205-D7F5E2A5FCB1 Q28385642-DE756C41-B847-441A-8D43-2C087D5C8977 Q28548386-6F312D32-7801-498E-AC09-1F388743DD29 Q33299753-FC3E25E8-0D15-447B-94A6-F93C603CD9DA Q33572324-59C7146A-FE72-460C-993D-5E3383AC89CA Q33674909-327941C0-88B0-496A-B756-A8A634919216 Q33722285-1BEB1D07-E345-4FB0-A15C-52A72C86E66C Q33777106-F45CA6FC-2C7D-41B4-8264-F6BCAA72F4E0 Q34389709-B7100FAB-3D9B-4596-AACE-8AFE5C0F8F3D Q34429613-F99935F7-688F-488A-A4AA-6C33D8CE5B7C Q34700590-7678991A-B521-4650-AB49-83A899FFE5A9 Q35011789-3F78ACA0-B9A6-4F5D-9C55-EEA3881D0E70 Q35032772-8E8BFA54-5098-4131-B205-C87811788E24 Q35097232-51B904AB-6006-4370-9F2A-5603D52E4361 Q35152942-7345F31A-B918-4AD1-A736-0FC39822FC04 Q35522878-3CF858D7-3CEE-4B08-A547-A4AE227A4D58 Q35544606-AF8E6433-9F89-48E4-888F-2D3DBB9BD64B Q35560868-B06242A9-BFBC-4ABB-A5AA-3B80C8531656 Q35679531-8E9BB9BD-1E6B-4BC5-8C24-7586A699C539 Q35771675-A68E07A2-791B-49D8-B95D-39C0D79B9AFC Q35863203-E355712D-ADC9-4C38-871A-2EF9814D38F7 Q35889072-047ACEF9-56BC-49D2-A6B7-292E78AA575C Q35970241-DEBBB7F3-AC17-45E4-A453-3D7557DC8C69 Q36061114-B27ACE0A-5BD2-44B5-8238-62F0983EE54D Q36065252-F6211AF9-F40D-42C1-9A3B-106416CA8A36 Q36110403-1425B172-811B-429B-8B98-476D29F2EF23 Q36139562-24C8D8F7-1A38-4F87-83C1-9700C8E4B904 Q36201267-EB52B7AC-8F3A-4C09-A196-32D59424F35A Q36216250-761C7808-520A-45CF-8F0A-2D1DC0B12822 Q36228782-8B20A749-AF1C-48FE-B1DC-724F4E886F0B Q36294753-E9D22640-431C-44CA-A71A-4F04B517EA5B Q36296167-48D85B3E-6E62-4CBA-9B11-CC5060F78B13 Q36412671-90F7F6D3-9632-4FFF-A275-ABB4E8DC307D Q36514299-9CA43942-8791-4027-B526-D5EACE573BD3

P2860

Wnt/beta-catenin signaling pathway as a novel cancer drug target.

http://www.wikidata.org/entity/Q35971885

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Wnt/beta-catenin signaling pathway as a novel cancer drug target.

@ast

Wnt/beta-catenin signaling pathway as a novel cancer drug target.

@en

type

label

Wnt/beta-catenin signaling pathway as a novel cancer drug target.

@ast

Wnt/beta-catenin signaling pathway as a novel cancer drug target.

@en

prefLabel

Wnt/beta-catenin signaling pathway as a novel cancer drug target.

@ast

Wnt/beta-catenin signaling pathway as a novel cancer drug target.

@en

P1433

Q35971885-9DB5DEBF-D161-43C6-B68D-07A66194D518

P1476

Q35971885-E5F480BE-791C-442F-9D43-F0CB09B8D8A0

P2093

Q35971885-1AD68FD6-4CA9-4F60-962E-1C4551BCF77E

Q35971885-274FA8C3-00CB-408A-967E-41404D27E902

Q35971885-32049A6A-CCA3-4BD4-937D-23493DFC49E3

Q35971885-51B4C8B2-17B0-49FD-9699-1D4CCC0DF853

Q35971885-8D1394FF-E3C7-47CF-9EEE-16782EE31206

Q35971885-CCB82F13-3F60-4A9C-BFA6-1DFCE44F7E9F

Q35971885-D72C6160-B22B-4DD4-B1D1-88C2B17A57E3

Q35971885-FE1FBF08-4E86-4DD5-837B-F43F48D7F593

P304

Q35971885-30B9A61F-0F58-42FD-A400-A1E3CBC59B60

P31

Q35971885-EB4722B7-5853-4093-AE73-994E8189EDDF

P356

Q35971885-4C1A4B6B-2052-49E9-8C99-146AD8B3BD28

P433

Q35971885-25746ECA-1F8E-4BA0-A711-784292CE2E11

P478

Q35971885-6602BA5D-C765-4BDF-BAF7-F87F9DF8D591

P50

Q35971885-3B63A704-2A57-4A90-BAB9-B18A1EE41A47

Q35971885-E61C1468-C9E7-4EF3-8559-0E2C2A3DEB08

Q35971885-F6EE73BD-9413-4A47-943F-4FA649289134

P577

Q35971885-6BF0AE1A-500F-4969-8498-22226202E2EA

P5875

Q35971885-F7B3D01C-A577-4349-BEC1-1B9C400DA9DC

P698

Q35971885-40765E92-887C-4E5E-9317-1F51937E8D9E

P356

1568009043332709

P1433

Current Cancer Drug Targets

P1476

Wnt/beta-catenin signaling pathway as a novel cancer drug target.

@en

P2093

Hue H Luu

http://www.w3.org/2001/XMLSchema#string

Jong Kyung Park

http://www.w3.org/2001/XMLSchema#string

Quan Kang

http://www.w3.org/2001/XMLSchema#string

Rex C Haydon

http://www.w3.org/2001/XMLSchema#string

Tong-Chuan He

http://www.w3.org/2001/XMLSchema#string

Wei Jiang

http://www.w3.org/2001/XMLSchema#string

Weike Si

http://www.w3.org/2001/XMLSchema#string

Ying Peng

http://www.w3.org/2001/XMLSchema#string

P304

653-671

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1568009043332709

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth R Rayburn

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8148759

http://www.w3.org/2001/XMLSchema#string

P698

15578921

http://www.w3.org/2001/XMLSchema#string